ArticleBlood cell therapy2026

Ruxolitinib-associated pulmonary alveolar proteinosis successfully managed by switching to belumosudil in chronic graft-versus-host disease.

Hiroaki Araie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.